BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37650886)

  • 21. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).
    Feindiri M; Kabbaj H; El Mzibri M; Belkadi B; Bouihat N; Filali-Maltouf A; Seffar M
    Intervirology; 2022; 65(2):80-86. PubMed ID: 34518480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.
    Tang Z; Li X; Wu S; Liu Y; Qiao Y; Xu D; Li J
    Hepatol Int; 2017 Sep; 11(5):429-433. PubMed ID: 28856548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
    Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
    Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
    Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.
    Mozessohn L; Chan KK; Feld JJ; Hicks LK
    J Viral Hepat; 2015 Oct; 22(10):842-9. PubMed ID: 25765930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
    Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital.
    De Conto F; Buttrini M; Dell'Anna ML; Maccari C; Montanari G; Arcangeletti MC; Martinelli M; Chezzi C; Calderaro A
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101892. PubMed ID: 35202845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.
    Shen YZ; Wang ZY; Qi TK; Jiang XY; Song W; Tang Y; Wang JR; Liu L; Zhang RF; Zheng YF; Dai ZS; Lu HZ
    HIV Med; 2013 Mar; 14(3):167-75. PubMed ID: 22998624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran.
    Taherkhani R; Farshadpour F
    PLoS One; 2022; 17(3):e0265063. PubMed ID: 35271684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Merli M; Rattotti S; Gotti M; Arcaini L
    Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
    Engels EA; Cho ER; Jee SH
    Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of Hepatitis B Virus Envelope Antigen and Antibodies Among Chronic Carriers in Ibadan, Nigeria.
    Farinloye OI; Otunola A; Fowotade A; Faneye AO
    Viral Immunol; 2021 May; 34(4):284-287. PubMed ID: 33999720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical analysis of stages of HBV infection in 100 cases of lymphoma.
    Tang Y; Sun LG; Liu CS; Li YY; Jin CH; Li D; Bai O
    Asian Pac J Cancer Prev; 2013; 14(2):959-62. PubMed ID: 23621268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
    Tien YC; Yen HH; Li CF; Liu MP; Hsue YT; Hung MH; Chiu YM
    Arthritis Res Ther; 2018 Nov; 20(1):246. PubMed ID: 30382902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.